126 related articles for article (PubMed ID: 38521148)
21. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
22. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
[TBL] [Abstract][Full Text] [Related]
23. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
24. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
[TBL] [Abstract][Full Text] [Related]
25. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
26. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography in the acute and chronic phases of Vogt-Koyanagi-Harada disease.
Parc C; Guenoun JM; Dhote R; Brézin A
Ocul Immunol Inflamm; 2005; 13(2-3):225-7. PubMed ID: 16019683
[TBL] [Abstract][Full Text] [Related]
28. [The fundus manifestations and SD-OCT findings of patients with acute Vogt-Koyanagi-Harada disease].
Li B; Ye JJ; Zhang MF; Li DH
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):436-439. PubMed ID: 28606265
[No Abstract] [Full Text] [Related]
29. Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report.
Onoe H; Shimada H; Kawamura A; Hirosawa H; Tanaka K; Mori R; Nakashizuka H
BMC Ophthalmol; 2022 Feb; 22(1):91. PubMed ID: 35197001
[TBL] [Abstract][Full Text] [Related]
30. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Ishihara K; Hangai M; Kita M; Yoshimura N
Ophthalmology; 2009 Sep; 116(9):1799-807. PubMed ID: 19643489
[TBL] [Abstract][Full Text] [Related]
31. Choroidal Detachment following an Intravitreal Injection in a Patient with Vogt-Koyanagi- Harada Disease.
Kumar N; Rana N; Bansal R
Ocul Immunol Inflamm; 2021 Feb; 29(2):396-398. PubMed ID: 31664881
[No Abstract] [Full Text] [Related]
32. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Maruyama Y; Kishi S
Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
[TBL] [Abstract][Full Text] [Related]
33. Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.
Yang HK; Yu HG
Korean J Ophthalmol; 2009 Dec; 23(4):325-8. PubMed ID: 20046700
[TBL] [Abstract][Full Text] [Related]
34. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
Yamamoto N; Naito K
Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
[TBL] [Abstract][Full Text] [Related]
35. Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging.
Aggarwal K; Agarwal A; Deokar A; Mahajan S; Singh R; Bansal R; Sharma A; Dogra MR; Gupta V;
J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):3. PubMed ID: 28091938
[TBL] [Abstract][Full Text] [Related]
36. Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis.
Fabro F; Herbort CP
Klin Monbl Augenheilkd; 2018 Apr; 235(4):424-435. PubMed ID: 29669371
[TBL] [Abstract][Full Text] [Related]
37. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
Han YS; Shin KS; Lee WH; Kim JY
Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of retinal pigment epithelial detachment in Vogt-Koyanagi-Harada disease: a longitudinal analysis.
Zheng C; Wang K; Zhang M; Tao Q; Li X; Zhang X
BMC Ophthalmol; 2022 Nov; 22(1):446. PubMed ID: 36401187
[TBL] [Abstract][Full Text] [Related]
39. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy].
Doga AV; Klepinina OB; Pedanova EK; Mushkova IA
Vestn Oftalmol; 2017; 133(6):10-15. PubMed ID: 29319664
[TBL] [Abstract][Full Text] [Related]
40. Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
Yamaguchi Y; Otani T; Kishi S
Am J Ophthalmol; 2007 Aug; 144(2):260-5. PubMed ID: 17533104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
